1.60BMarket Cap
LossP/E TTM
Harrow Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Harrow Inc is 9.50, ranking 14 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -111.38, which is -90.15% below the recent high of -10.97 and -277.18% above the recent low of -420.12.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.